Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03416504 · ClinicalTrials.gov registry record · NA

Methods for Managing Intrusive Thoughts

A NA study of Obsessive - Compulsive Disorder, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT03416504 is a NA study of Obsessive - Compulsive Disorder that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 40 participants, below the 2,064-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03416504, a NA study of Obsessive - Compulsive Disorder, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The current study sought to translate laboratory research on learning and memory to better understand the mechanisms and methods for implementing exposure therapy for unwanted obsessional thoughts. Specifically, we compared the processes and the short- and long-term outcomes of: (a) gradual exposure (EXP-G), emphasizing hierarchical exposure completion, versus (b) variable exposure (EXP-V), emphasizing variability in exposure intensity.

Interventions

  • BEHAVIORAL Gradual Exposure (EXP-G)
  • BEHAVIORAL Variable Exposure (EXP-V)

Study Locations (1)

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2015-09-22
Est. Completion 2016-10-04
Phase NA

What the Registry Record Tells You About NCT03416504

The ClinicalTrials.gov registry entry for NCT03416504 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,064-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (98% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obsessive - Compulsive Disorder appearing as the primary indexed condition, and to 2 interventions - of which Gradual Exposure (EXP-G) is the first listed.

NCT03416504 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT03416504 about?

NCT03416504 is a clinical study titled "Methods for Managing Intrusive Thoughts". The current study sought to translate laboratory research on learning and memory to better understand the mechanisms and methods for implementing exposure therapy for unwanted obsessional thoughts. Specifically, we compared the processes and the short- and long-term outcomes of: (a) gradual exposure...

What is the current status of trial NCT03416504?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2015-09-22. Estimated completion is 2016-10-04.

What conditions does trial NCT03416504 study?

This clinical trial studies the following conditions: Obsessive - Compulsive Disorder.

What interventions are being tested in trial NCT03416504?

The interventions under investigation include: Gradual Exposure (EXP-G) (BEHAVIORAL), Variable Exposure (EXP-V) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03416504?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03416504 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obsessive - Compulsive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.